Arcutis Biotherapeutics Gross Margin Growth & History (ARQT)
Arcutis Biotherapeutics's gross margin was 90.14% for fiscal 2025.
View full Arcutis Biotherapeutics company overviewArcutis Biotherapeutics annual gross margin history
2022
2023
2024
2025
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 90.14% | +1.62 pp |
| 2024 | 2024-12-31 | 88.51% | +5.60 pp |
| 2023 | 2023-12-31 | 82.91% | +3.37 pp |
| 2022 | 2022-12-31 | 79.54% | — |
Arcutis Biotherapeutics quarterly gross margin
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 91.58% | +0.77 pp |
| Q1 2026 | 2026-03-31 | 90.72% | +4.55 pp |
| Q4 2025 | 2025-12-31 | 90.83% | +0.79 pp |
| Q3 2025 | 2025-09-30 | 91.25% | +3.54 pp |
| Q2 2025 | 2025-06-30 | 90.81% | +2.03 pp |
| Q1 2025 | 2025-03-31 | 86.17% | +1.27 pp |
| Q4 2024 | 2024-12-31 | 90.04% | +6.65 pp |
| Q3 2024 | 2024-09-30 | 87.70% | +2.28 pp |
| Q2 2024 | 2024-06-30 | 88.77% | +5.04 pp |
| Q1 2024 | 2024-03-31 | 84.90% | +13.06 pp |
| Q4 2023 | 2023-12-31 | 83.39% | — |
| Q3 2023 | 2023-09-30 | 85.42% | — |
| Q2 2023 | 2023-06-30 | 83.73% | — |
| Q1 2023 | 2023-03-31 | 71.84% | — |
Arcutis Biotherapeutics gross margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Arcutis Biotherapeutics's gross margin increased from 79.54% to 90.14%, a change of +10.59 percentage points. The latest reported quarter, Q2 2026, shows 91.58%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arcutis Biotherapeutics source filings ↗